Product analysis
Hawthorn Berry 1500 mg offers an economical hawthorn supplement. Heart-related findings come from specific clinical extracts and do not establish routine cardiovascular benefits from this preparation.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The hawthorn species is identified. There is not enough information to judge its form quality or establish a match to studied extracts.
Ingredient Transparency100
The hawthorn amount and species are disclosed. Those details make the declared serving straightforward to check.
Value For Money100
The labeled serving is inexpensive. Its low cost does not establish a match to the extracts used in clinical research.
Customer Satisfaction71
Customer ratings are very positive. The smaller review pool leaves more uncertainty, and ratings do not prove effectiveness or safety.
Product Focus73
A single botanical keeps the formula focused on heart-related aims. Mixed findings from specific clinical extracts leave the benefit of this preparation uncertain.
- Format
Capsule - Container
- 90 Capsule(s)
- Per serving
- $0.32
- Customer rating
- 4.7 · 57 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Hawthorn (Crataegus monogyna) | 1500 mg |
How this ingredient is rated
Composition and Label Disclosure57
Marker and Preparation Disclosure
Species Name Disclosure
Composition and Label Disclosure
Commercial Price and Usability100
Commercial Price per Labeled Serving
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Real world effectiveness of Hawthorn special extract WS 1442 in a retrospective cohort study from Germany.
- Hawthorn (Crataegus spp.) Clinically Significantly Reduces Blood Pressure in Hypertension: A Meta-Analysis of Randomized Placebo-Controlled Clinical Trials.
- A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
- [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)].
- Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
- [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
- Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.
- Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II.
- Baseline severity but not gender modulates quantified Crataegus extract effects in early heart failure--a pooled analysis of clinical trials.